Comparative effectiveness of autologous haematopoietic stem cell transplantation vs. fingolimod, ocrelizumab and natalizumab in relapsing-remitting MS
38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Amsterdam, Netherlands, 26 - 28 October 2022, vol.28, pp.11-14, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 28
- City: Amsterdam
- Country: Netherlands
- Page Numbers: pp.11-14
- Karadeniz Technical University Affiliated: Yes